Researchers in Hong Kong have discovered a link between erectile dysfunction and heart problems.

In a study published in the May edition of the Journal of the American College of Cardiology, the scientists found that coronary problems could be predicted in men who had both type 2 diabetes and erectile dysfunction.

They examined 2,306 patients, 26.7 per cent of whom had erectile dysfunction at the start of the investigation.

The researchers from the Chinese University of Hong Kong found that coronary heart disease was more common in those with erectile dysfunction than those without.

Erectile dysfunction was said to be one of a number of factors which could be used to predict the likelihood of an incidence of heart disease including age, how long they had had diabetes and the use of antihypertensive agents and albuminuria.

The report concluded that "in type 2 diabetic men without clinically overt cardiovascular disease, the presence of erectile dysfunction predicts a new onset of coronary heart disease events".

It recommended that physicians look for signs of erectile dysfunction when examining patients who are already considered likely to inherit heart problems.

According to the Sexual Dysfunction Association, one in ten men in the UK has recurring problems with their erections during their lifetime.

Login and visit the Men's Health Knowledge Centre

• Viagra can exaggerate effects of heart-protective protein 06/01/09
• Vitamin K link to insulin resistance 27/11/08
• Erectile dysfunction linked to motorbikes in study 26/11/08
• Trauma link with sexual dysfunction 14/10/08
• Meat increases prostate cancer risk, study suggests 08/10/08

• LEUKERAN Tablets - 24.36%
  Leukeran is indicated in the treatment of Hodgkin's disease, certain forms of non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, and Waldenstrom's macroglobulinaemia ...
  
  
• CONCERTA XL Prolonged-release Tablets - 23.54%
  ... with ADHD and the decision to use the drug must be based on a very thorough assessment of the severity and chronicity of the child's symptoms in relation to the child's age. Use of CONCERTA® XL should be limited to patients requiring a product with effects lasting through the day to the evening when ...
  
  
• DATSCAN 74 MBq/ml solution for injection - 23.54%
  ... in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy. DaTSCAN is unable to discriminate between Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy ...
  
  
• SALAZOPYRIN - 23.54%
  Salazopyrin Tablets, Salazopyrin EN-Tablets, Salazopyrin Suspension: Ulcerative colitis. Crohn's disease. Salazopyrin Suppositories and Salazopyrin Enema: Ulcerative colitis and Crohn's colitis of the rectum ...
  
  
• PREDSOL (colitis) - 23.54%
  Predsol Enema: Rectal and rectosigmoidal disease in ulcerative colitis and Crohn's disease. Predsol Supositories: Proctitis and anal complications of Crohn's disease ...
  
  
• REMICADE (Crohn's disease) - 23.54%
  Treatment of severe active Crohn's disease in patients unresponsive to a full and adequate course of corticosteroid and/or immunosuppressant therapy; treatment of fistulising Crohn's disease, in patients unresponsive to a full and adequate course of therapy with conventional treatment. Also ...